what progress is there on an actual product?25 Feb 2022 10:46
This is the question I keep asking myself about this stock. I'd like an update on the progress against the attributes set out for success from the paraytec website. The critical one for me is the shoebox. It would seem that if we dont have that there is no way of getting the super refined test into customers hands. What is the manufacturing path/price point/distribution/support etc. The current portfolio of Paraytecs products looks like it focusses on lab based analytic devices so the mass production required for this doesnt seem to fit. If partners/purchasers are dropping away thats not good news.
Simple swab or saliva sample – no clinical expertise needed
No complex sample preparation – proprietary single-use cartridge containing analytes
Simple portable reader – shoebox size
No clinical training needed – automated test can be used in any location
Rapid result – sample to result in 5 to 10 minutes, potential for further reduction
yes/no result – option for quantification of viral load
Platform technology – can potentially be used to detect multiple virus targets
Anyway, It's been a learning experience that I can afford and I'll look hold my remaining shares at their 66%loss